Related Experiment Videos
Differential expression of transforming growth factor-beta isoforms in human prion diseases
1Department of Neuropathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Abstract:
To examine the involvement of transforming growth factor-beta (TGF-beta) in the pathogenesis of prion diseases, immunohistochemical studies on both TGF-beta isoforms (beta 1, beta 2 and beta 3) and TGF-beta receptor type II (TGF-beta RII) were performed on the cerebral neocortices of 20 cases with human prion diseases, three cases with Alzheimer's disease, and five control cases. TGF-beta 2 immunoreactivity was thus detected in most neurons and astrocytes in all observed cases of prion disease. TGF-beta 3 immunoreactivity in the astrocytes and TGF-beta RII in the neurons were also detected in 17 of 20 cases with prion diseases. These immunoreactivities had increased markedly regarding the intensity and the number of positive cells in comparison to the control cases, but they were indistinguishable from those observed in Alzheimer's disease cases. In contrast, the TGF-beta 1 immunostaining did not show any apparent difference. Among the cases with prion diseases, however, no significant correlation was revealed between the immunohistochemical results and the clinical and pathological features. The results showed that TGF-beta isoforms thus appear to be differentially involved in the pathogenesis of prion diseases in a similar manner to that of Alzheimer's disease. Furthermore, two cases of prion disease in which pathological findings were free from astrogliosis and neuronal cell degeneration in the cerebral cortices also showed an increased immunoreactivity for TGF-beta 2. Thus, this result suggests that TGF-beta 2 may be involved in the early stages of neuronal cell degeneration in prion diseases.
Insights
Transforming growth factor-beta (TGF-beta) 2 and 3 were elevated in prion diseases, similar to Alzheimer's disease. TGF-beta 2 may play a role in early neuronal degeneration in prion diseases.
Area of Science:
- Neuroscience
- Pathology
- Immunohistochemistry
Background:
- Prion diseases are fatal neurodegenerative disorders.
- The role of transforming growth factor-beta (TGF-beta) in prion disease pathogenesis is not well understood.
- Previous studies suggest TGF-beta involvement in other neurodegenerative conditions like Alzheimer's disease.
Purpose of the Study:
- To investigate the expression of TGF-beta isoforms (beta 1, beta 2, beta 3) and TGF-beta receptor type II (TGF-beta RII) in human prion diseases.
- To compare TGF-beta expression patterns in prion diseases with Alzheimer's disease and control cases.
- To explore the potential role of TGF-beta in the early stages of neuronal degeneration in prion diseases.
Main Methods:
- Immunohistochemical analysis of TGF-beta isoforms and TGF-beta RII in brain tissue.
- Study included 20 cases of human prion disease, 3 cases of Alzheimer's disease, and 5 control cases.
- Quantitative and qualitative assessment of immunoreactivity in neurons and astrocytes.
Main Results:
- TGF-beta 2 and TGF-beta 3 immunoreactivity were significantly increased in neurons and astrocytes in prion disease cases compared to controls.
- TGF-beta RII was detected in neurons in most prion disease cases.
- TGF-beta 1 showed no significant difference, and expression patterns were similar to Alzheimer's disease cases.
- Increased TGF-beta 2 immunoreactivity was observed even in prion disease cases without significant astrogliosis or neuronal degeneration.
Conclusions:
- TGF-beta isoforms are differentially expressed in prion diseases, with TGF-beta 2 and 3 showing increased levels.
- The expression patterns of TGF-beta in prion diseases resemble those found in Alzheimer's disease.
- TGF-beta 2 may be implicated in the early pathogenesis of neuronal cell degeneration in prion diseases.